{"member_organisations": "Same as above \n \nhttp://www.rpharms.com/talking-to-government/european-union-activity.asp", "identification_number": "26683956563-83", "fields_of_interest": "General and Institutional Affairs, Economy, finance and the euro, Culture and media, Budget, Competition, Customs, Education and training, Employment and Social Affairs, Taxation, Justice and Fundamental Rights, Regional Policy, Research and innovation, Trans-European Networks, Public Health", "head_office_address": "66-68 East Smithfield", "full_time_equivalent_fte": "0,5", "person_with_legal_responsibility": "Kimberley Shields", "inter_groups": "", "financial_year_start_date": "01/04/2016", "grants": "", "head_office_country": "United Kingdom", "eu_initiatives": "The Royal Pharmaceutical Society follows any policy pertaining to pharmacy professional practice.", "organisation_name": "Royal Pharmaceutical Society of Great Britain (RPS)", "belgium_office_post_code": "", "number_of_persons_involved": "2", "procurement": "", "section": "II - In-house lobbyists and trade/business/professional associations", "source": "", "belgium_office_address": "", "subsection": "Trade and business associations", "belgium_office_phone": "", "number_of_ep_accredited_persons": "", "overall_budget_turnover_as_a_range": "", "belgium_office_city": "", "persons_accredited_for_access_to_european_parliament_premises": "", "estimate_of_costs_absolute_amount": "", "registration_date": "05/09/2011", "website_address": "http://www.rpharms.com/home/home.asp", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "London", "membership": "RPS is a membership organisation \n \nFIP - Federation International Pharmaceutical \nPGEU - Pharmaceutical Group of the European Union", "head_office_post_code": "E1W 1AW", "goals__remit": "The Royal Pharmaceutical Society believes that pharmacists should be: \n \n\u2022The recognised professional member of the healthcare team responsible for choosing \nPharmacotherapy \n \n\u2022The universally accessible frontline clinical provider of all aspects of pharmaceutical care \n \n\u2022The healthcare professional entrusted by patients to take care of their every pharmaceutical need \n \n\u2022The recognised expert professional for medicines governance, information and management \n \n\u2022The guardian of patient safety and welfare, maximising the benefits of medicines and minimising the risks caused by adverse effects \n \n\u2022The leader in pharmaceutical innovation, research and developments of medicines, and of the delivery of pharmaceutical services \n \n\u2022The patient\u2019s safeguard in the research, design, manufacture and supply of quality assured medicines \n \n\u2022The educator of all health professionals, the public and patients on the safe and effective use of medicines \n \n\u2022Accessible to all patients as a source of advice on health improvement and well-being", "industry_forums": "", "head_office_phone": "(+44)2075722737", "level_of_interest": "European, global, national", "relevant_communication": "We influence at EU, UK, Scotland and Wales government.  \n \nWe are also members of campaigning coalitions who influence government policy at those levels as well.", "financial_year_end_date": "01/03/2017", "estimate_of_costs_as_a_range": "25000-49999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "Company incorporated by Royal Charter", "person_in_charge_of_eu_relations": "Alina Lourie", "customers": "", "belgium_office_post_box": "", "position": "Managing Director - Pharmaceutical Press"}